Evidence map›Paper›PMID 40071277›Full record

ArticleFrontiers in psychiatry2025

Randomized controlled trial to assess medication adherence and health-related quality of life through a collaborative pharmacist-psychiatrist approach to patient education in patients with depression in India.

Ambed Mishra, Manohar Rao Kishor, Madhan Ramesh

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ambed MishraDepartment of Community Medicine, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysore, Karnataka, India.
Manohar Rao KishorDepartment of Psychiatry, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysore, Karnataka, India.
Madhan RameshDepartment of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Depression is a common but severe mental health disorder affecting individuals globally. Medication non-adherence and low health-related quality of life (HRQoL) are the major challenges associated with the treatment of patients with depression. Materials and methods: A prospective Randomized Controlled Trial (RCT) was conducted in the psychiatry outpatient department of a tertiary care hospital for six months. Patients were assigned to either a control group receiving usual care or a test group receiving collaborative care using simple randomization technique. The eligible patients diagnosed with depression were enrolled and the data were collected from patient's care records, prescriptions, patient interviews, patient representatives and healthcare professionals. The intervention in the test group consisted of comprehensive patient education, including a thorough counseling session with a research clinical pharmacist. Counseling sessions included information on the disease, medications prescribed, possible side effects, compliance with medications and overall treatment. The data collected from both patient groups was analyzed for medication adherence using the Medication Adherence Rating Scale (MARS) and health-related quality of life (HRQoL) using the WHOQOL-BREF questionnaire. Statistical analyses were performed using a student t-test with a significance level of P value < 0.05. Results: The collaborative care group showed a statistically significant improvement in medication adherence, with a mean increase of 1.67 ± 0.25 (P < 0.001), compared with a mean increase of 0.69 ± 0.05 (P < 0.05) for the usual care group. Similarly, HRQoL scores also improved significantly more in the collaborative care group, with a mean increase of 28.01 ± 2.05 (P < 0.001), compared with a mean increase of 12.46 ± 0.26 (P < 0.05) for the usual care group. Conclusion: This study concluded that pharmacist-psychiatrist collaborative patient education can significantly improve the medication adherence and HRQoL of the patients with depression. Statistically significant increases in medication adherence and HRQoL were observed in the collaborative group.

Indexed as

depressionmedication adherencemental healthpharmacypsychiatryquality of life

Identifiers

PMID40071277
PMCPMC11894377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.